Chancellor Reeves Aims for Targeted Measures on Bills in Upcoming Financial Plan
Treasury head Rachel Reeves has stated she is preparing "targeted steps to address household expense issues" in the forthcoming financial statement.
In comments to media outlets, she noted that lowering inflation is a collective duty of both the government and the Bank of England.
The United Kingdom's inflation rate is expected to be the highest among the Group of Seven advanced economies this calendar year and next.
Possible Utility Bill Measures
Sources suggest the government could intervene to reduce energy bills, for example by slashing the present 5% rate of VAT applied on energy.
A further possibility is to lower some of the government charges presently added to bills.
Fiscal Constraints and Expert Expectations
The administration will obtain the latest report from the official forecaster, the OBR, on Monday, which will reveal how much scope there is for these measures.
The expectation from most analysts is that the Chancellor will have to declare tax increases or expenditure reductions in order to fulfill her self-imposed debt limits.
Previously on Thursday, estimates indicated there was a twenty-two billion pound shortfall for the chancellor to fill, which is at the lower end of expectations.
"There's a joint task between the Bank of England and the administration to bear down further on some of the drivers of price increases," Reeves told the BBC in the US capital, at the annual meetings of the IMF and World Bank.
Tax Commitments and Global Issues
While much of the focus has been on probable tax increases, the chancellor said the most recent data from the OBR had not altered her vow to manifesto promises not to raise rates on earnings tax, VAT or social security contributions.
She attributed an "unpredictable world" with rising geopolitical and commercial concerns for the fiscal revenue measures, likely to be directed on those "most able to pay."
Global Economic Tensions
Addressing worries about the United Kingdom's economic relations with China she said: "Our security interests always are paramount."
Last week's announcement by Chinese authorities to strengthen trade restrictions on rare earths and other materials that are crucial for high-technology manufacturing led American leader the US President to threaten an additional 100% import tax on goods from the Asian country, increasing the possibility of an all-out trade war between the two largest economies.
The American finance chief described the Chinese action "commercial pressure" and "a global supply chain power grab."
Questioned on accepting the US offer to participate in its conflict with China, the Chancellor said she was "deeply worried" by China's actions and encouraged the Beijing authorities "to avoid restrictions and limit trade."
She said the decision was "bad for the global economy and generates further obstacles."
"It is my opinion there are sectors where we must address Chinese policies, but there are also valuable prospects to export to Chinese markets, including banking sector and other areas of the economic system. We've got to maintain that balance appropriate."
The Treasury chief also stated she was collaborating with other major economies "regarding our own essential resources approach, so that we are less reliant."
Health Service Medicine Pricing and Funding
Reeves also recognized that the price the NHS pays for pharmaceuticals could increase as a result of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.
A number of the biggest global drug companies have said in recent statements that they are either pausing or abandoning investments in the United Kingdom, with some blaming the low prices they are getting.
Last month, the Science Minister said the cost the health service pays for medicines would have to increase to halt firms and drug research funding departing from the UK.
The Chancellor informed the BBC: "It has been observed due to the pricing regime, that medical research, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."
"The objective is to guarantee that individuals receiving treatment from the National Health Service are able to obtain the top essential treatments in the world. And so we are reviewing all of that, and... aiming to secure increased funding into Britain."